newsfilter
← Latest News
GlobeNewswire·

CapsoVision Submits Breakthrough Device Designation Application to FDA for Pancreatic Cancer Screening Capsule

CV

SARATOGA, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ:CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced